SSII-3 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SSII-3 antibody; ALK antibody; Os06g0229800 antibody; LOC_Os06g12450 antibody; P0525F01.23 antibody; Soluble starch synthase 2-3 antibody; chloroplastic/amyloplastic antibody; EC 2.4.1.21 antibody; Soluble starch synthase II-3 antibody; Starch synthase IIa antibody
Target Names
SSII-3
Uniprot No.

Target Background

Function
SSII-3 Antibody plays a crucial role in endosperm starch synthesis. It determines the amylopectin structure of starch grains by synthesizing long B1 amylopectin chains. This process involves elongating short A and B1 chains, independently of other soluble starch synthases. Notably, SSII-3 exhibits minimal activity in japonica subspecies.
Database Links

KEGG: osa:4340567

STRING: 39947.LOC_Os06g12450.1

UniGene: Os.5738

Protein Families
Glycosyltransferase 1 family, Bacterial/plant glycogen synthase subfamily
Subcellular Location
Plastid, amyloplast. Plastid, chloroplast. Note=Amyloplast or chloroplast, granule-bound and soluble.
Tissue Specificity
Expressed most exclusively in endosperm.

Q&A

What is SSII-3 and what different antibodies are available for research?

SSII-3 can refer to two distinct proteins requiring different antibodies:

  • Starch Synthase IIa (SSIIa) - A key enzyme in starch biosynthesis in plants, particularly cereals.

    • Available antibodies are primarily rabbit polyclonal antibodies raised against recombinant Oryza sativa SSIIa protein

    • Molecular weight: Approximately 88 kDa

    • Main applications: Western blot with samples from rice and other cereals

  • SOCS3 (Suppressor of cytokine signaling 3) - Sometimes abbreviated as SSI-3

    • Available as polyclonal antibodies (from rabbit, goat) and monoclonal antibodies (mouse, rabbit)

    • Molecular weight: Calculated 24.8-25 kDa, observed 28-30 kDa on Western blots

    • Main applications: WB, IHC, IF, ELISA across multiple species

How do I select the optimal antibody for my SSII-3/SOCS3 research?

Selection criteria should be based on:

  • Target specificity:

    • For plant SSIIa research, select antibodies raised against your species of interest or highly conserved regions (rice SSIIa antibodies often cross-react with other cereals)

    • For SOCS3 research, check specific reactivity with human/mouse/rat as needed

  • Application requirements:

    • For Western blotting: Both polyclonal and monoclonal work well

    • For immunohistochemistry: Validated antibodies for IHC-P specifically

    • For immunofluorescence: Antibodies validated for IF applications

  • Form and conjugation:

    • Unconjugated primary antibodies are most versatile

    • Consider pre-conjugated antibodies for specialized applications

Antibody TypeHostApplicationsWorking DilutionsAdvantages
SOCS3 PolyclonalRabbitWB, IHC, IFWB: 1:100-1:2000 IHC: 1:50-1:200Recognizes multiple epitopes
SOCS3 MonoclonalMouseWBWB: 1:1000Higher specificity, less batch variation
SSIIa PolyclonalRabbitWBWB: 1:500-1:2000Specific for plant starch synthase

What controls should be included when using SSII-3/SOCS3 antibodies?

For rigorous experimental design, include:

  • Positive controls:

    • For SOCS3: Lysates from HeLa, Jurkat, U937, or C2C12 cells

    • For SSIIa: Developing rice endosperm extracts

  • Negative controls:

    • For SOCS3: SOCS3 knockout/knockdown samples

    • For SSIIa: SSIIa mutant plant tissues

  • Loading controls:

    • Actin antibody for normalizing protein loading

    • GAPDH or other housekeeping proteins

  • Antibody validation controls:

    • Pre-absorption with immunizing peptide

    • Isotype control antibodies

    • Secondary antibody-only controls

What are the optimal protocols for Western blotting with SSII-3/SOCS3 antibodies?

For SOCS3 Western blotting:

  • Sample preparation: Extract proteins from cells/tissues using RIPA or similar buffer with protease inhibitors

  • Protein separation: 12% SDS-PAGE gels (4-10% gradient gels also work well)

  • Transfer conditions: Standard transfer to PVDF or nitrocellulose membrane

  • Blocking: 3-5% BSA or non-fat milk in PBST/TBST

  • Primary antibody incubation:

    • Polyclonal antibodies: 1:500-1:50,000 dilution

    • Monoclonal antibodies: 1:1,000 dilution

  • Detection: SOCS3 appears as a band at approximately 28-30 kDa

For SSIIa Western blotting:

  • Sample preparation: Extract proteins from developing seeds (optimal at 15 days after flowering)

  • Protein loading: 100 μg protein per lane recommended

  • Gel separation: 4-10% gradient gels

  • Antibody dilution: 1:500-1:2,000

  • Detection: SSIIa appears as a band at approximately 88 kDa

How should samples be prepared for subcellular fractionation to detect SSII-3 in plant tissues?

For effective subcellular fractionation of SSIIa from plant tissues:

  • Harvest developing seeds at optimal developmental stages (15 days after flowering recommended)

  • Flash-freeze samples in liquid nitrogen and store at -80°C

  • Prepare three protein fractions using differential extraction:

    • Soluble protein (SP): Extract with non-denaturing buffer

    • Loosely bound protein (LBP): Extract starch pellet with buffer containing detergent

    • Tightly bound protein (TBP): Extract remaining starch with SDS buffer

Research data indicates that SSIIa distribution between these fractions changes during seed development and differs between rice varieties:

  • Japonica rice varieties show reduced levels of SSIIa in the starch-associated fraction compared to indica varieties

  • Distribution patterns correlate with starch structure and functional properties

What are the optimal methods for detecting SOCS3 in tissue samples via immunohistochemistry?

For SOCS3 immunohistochemistry:

  • Tissue preparation:

    • Fix tissues in 4% paraformaldehyde or formalin

    • Embed in paraffin and section at 4-6 μm thickness

    • For optimal results, perform antigen retrieval using citrate buffer (pH 6.0) or TE buffer (pH 9.0)

  • Staining protocol:

    • Block endogenous peroxidase with H₂O₂

    • Block non-specific binding with serum or BSA

    • Incubate with primary antibody at 1:50-1:250 dilution

    • Use appropriate detection system (HRP/DAB recommended)

  • Validation:

    • Human liver tissue serves as a reliable positive control for SOCS3 staining

    • Include isotype control sections to assess background

How can researchers distinguish between different SS isoforms in immunodetection experiments?

Distinguishing between starch synthase isoforms requires careful experimental design:

  • Native-PAGE/SS activity staining:

    • Different SS isoforms show distinct migration patterns

    • SSI appears as a strong activity middle band

    • SSIIIa appears as the slowest migrating SS activity band

  • Western blotting with isoform-specific antibodies:

    • SSI: ~71 kDa

    • SSIIa: ~88 kDa

    • SSIIIa: ~230 kDa

  • Genetic approaches:

    • Use SS isoform-specific mutants as controls

    • Example: SSIIIa-deficient mutants lack the slowest migrating activity band on native gels

Research has shown that SS isoforms have distinct roles in starch biosynthesis:

  • SSI synthesizes short chains of amylopectin (DP 6-12)

  • SSIIa elongates short chains to medium-length chains (DP 13-25)

  • SSIIIa synthesizes longer chains (DP ≥30)

How can researchers distinguish between SOCS3 and other SOCS family members?

To differentiate SOCS3 from other SOCS family proteins:

  • Antibody selection:

    • Use antibodies targeting unique regions of SOCS3 not conserved in other SOCS proteins

    • Verify antibody specificity via manufacturer validation data

  • Molecular weight differentiation:

    • SOCS3 has a predicted molecular weight of ~25 kDa (observed ~28-30 kDa)

    • Other SOCS proteins have distinct molecular weights

  • Expression pattern analysis:

    • SOCS3 has characteristic expression patterns in specific cell types

    • Compare with known tissue-specific expression patterns of different SOCS proteins

  • Alternative approaches:

    • RT-qPCR with specific primers to distinguish at mRNA level

    • Multiple antibodies targeting different epitopes of SOCS3

    • SOCS3 knockout samples as negative controls

How should researchers interpret discrepancies between antibody-based protein detection and gene expression data?

When facing discrepancies between protein levels and gene expression:

  • For SOCS3 research:

    • Consider SOCS3's short protein half-life (rapidly degraded via proteasome)

    • Evaluate post-translational modifications affecting antibody detection

    • Examine temporal dynamics (protein levels may lag behind mRNA changes)

    • Investigate feedback mechanisms (SOCS3 participates in negative feedback regulation)

  • For SSIIa research:

    • Consider protein redistribution between soluble and granule-bound fractions

    • Examine compensatory changes in other starch synthase isoforms

    • Research shows SSIIIa deficiency triggers increased SSI activity through transcriptional regulation

    • Study protein complex formation affecting stability or antibody epitope accessibility

How can SOCS3 antibodies be used to study protein-protein interactions in JAK/STAT signaling?

Advanced techniques for studying SOCS3 interactions:

  • Co-immunoprecipitation (Co-IP):

    • Use SOCS3 antibodies to precipitate protein complexes

    • Western blot for known binding partners (JAK2, gp130, etc.)

    • Mass spectrometry to identify novel interactions

  • Proximity ligation assay (PLA):

    • Visualize in situ interactions between SOCS3 and binding partners

    • Requires primary antibodies against both SOCS3 and potential interactors

    • Generates fluorescent signal only when proteins are in close proximity (<40 nm)

  • FRET/BRET analysis:

    • Use SOCS3 antibodies to validate energy transfer results

    • Confirm protein-protein interactions detected by other methods

Research has established that SOCS3 interacts with:

  • Tyrosine kinase receptors (IL6ST/gp130, LIF, erythropoietin, insulin, IL12, GCSF, leptin receptors)

  • JAK2 (inhibiting its kinase activity)

  • Components of E3 ubiquitin-protein ligase complexes

How can SSIIa antibodies be used to investigate protein complexes in starch biosynthesis?

Advanced approaches for studying SSIIa protein complexes:

  • Immunoprecipitation of native complexes:

    • Use SSIIa antibodies to isolate protein complexes from developing endosperm

    • Identify interacting partners by Western blot or mass spectrometry

    • Research indicates SSIIa plays a scaffolding role in forming multi-enzyme complexes

  • Analysis of starch granule-associated proteins:

    • Use differential extraction followed by immunoblotting

    • Compare SS isoform distribution between soluble and granule-bound fractions

    • Research shows SSIIa affects the association of SSI and SBEIIb with starch granules

  • Blue native PAGE:

    • Separate native protein complexes

    • Detect SSIIa-containing complexes via immunoblotting

    • Secondary dimension SDS-PAGE to identify complex components

Research has revealed that:

  • SSIIa influences the distribution of other enzymes between starch granules and amyloplast stroma

  • Japonica and indica rice varieties differ in SSIIa association with starch granules

  • SSIIa forms functional complexes with other starch biosynthetic enzymes

How can researchers use SSIIa antibodies to investigate the relationship between SSIIa and starch digestibility?

This advanced research application connects molecular mechanisms to functional outcomes:

  • Correlating SSIIa protein levels with starch structure:

    • Use SSIIa antibodies to quantify protein in different rice varieties

    • Analyze amylopectin chain length distribution in the same samples

    • Research shows SSIIa affects medium-chain amylopectin (DP 13-36)

  • Studying SSIIa downregulation effects:

    • Use antibodies to confirm reduced SSIIa protein levels in transgenic/mutant plants

    • Analyze changes in starch structure and digestibility

    • Research reveals reduced SSIIa expression decreases glycemic index estimate by 25%

  • Investigating SSIIa allelic effects:

    • Use antibodies to compare protein levels between varieties with different SSIIa alleles

    • Correlate with functional starch properties

    • Research shows SSIIa alleles determine peak gelatinization temperature of rice

SSIIa StatusAmylose ContentMedium-Chain AmylopectinGlycemic IndexStarch Granule Morphology
Normal expressionNormalNormalHigherPolygonal, sharp edges
Reduced expressionNo significant changeReduced proportionLower (↓25%)Rounder, irregular surfaces
SSIIa mutationIncreasedAltered patternLowerSmaller, round shaped

What are common issues in Western blotting with SOCS3/SSII-3 antibodies and how can they be resolved?

ProblemPossible CausesSolutions
No signalProtein degradationAdd protease inhibitors, avoid freeze-thaw cycles
Insufficient primary antibodyOptimize antibody concentration (1:500-1:2000)
Insufficient antigenIncrease protein loading or use enrichment techniques
Multiple bandsNon-specific bindingUse more stringent washing, optimize blocking
Antibody cross-reactivityTry monoclonal antibodies for higher specificity
Protein degradationAdd protease inhibitors, prepare fresh samples
High backgroundInsufficient blockingIncrease blocking time or concentration
Excessive antibodyFurther dilute primary/secondary antibodies
Insufficient washingIncrease washing duration and number of washes

How can researchers optimize immunohistochemistry protocols for difficult tissues?

For challenging tissue samples:

  • Antigen retrieval optimization:

    • Test multiple methods: heat-induced (citrate buffer pH 6.0 vs. TE buffer pH 9.0)

    • Adjust retrieval time and temperature

    • For plant tissues, consider enzymatic digestion of cell walls

  • Antibody concentration and incubation:

    • Titrate antibody concentrations (starting at 1:50-1:200)

    • Test extended incubation times (overnight at 4°C)

    • Consider signal amplification systems for weak signals

  • Background reduction:

    • Pre-absorb antibodies with tissue powder

    • Block endogenous enzymes (peroxidase/phosphatase)

    • Use specialized blocking reagents (animal-free blockers)

  • Tissue-specific considerations:

    • For high-lipid tissues: modify fixation and processing

    • For plant tissues: optimize fixation to preserve antigen while permeabilizing cell walls

    • For highly autofluorescent tissues: use appropriate quenching methods

How do post-translational modifications affect antibody recognition of SOCS3/SSII-3?

Post-translational modifications can significantly impact antibody detection:

  • For SOCS3:

    • Phosphorylation may alter epitope accessibility

    • Ubiquitination (SOCS3 is rapidly degraded by proteasome)

    • The observed molecular weight (~28-30 kDa) exceeds the calculated weight (24.8 kDa), suggesting modifications

  • For SSIIa:

    • Phosphorylation may affect activity and protein interactions

    • Protein complex formation may mask epitopes

    • Association with starch granules can affect extraction and detection

Strategies to address PTM effects:

  • Use multiple antibodies targeting different epitopes

  • Include phosphatase treatment controls

  • Consider proteasome inhibitors for SOCS3 studies

  • For SSIIa, compare different extraction methods to capture all protein forms

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.